| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/1992 | US5143908 Antibacterial agents and potentiators of carbapenem antibiotics |
| 09/01/1992 | US5143907 Phosphite-borane compounds, and method of making and using the same |
| 09/01/1992 | US5143906 Kedarcidin antitumor chromophore and pharmaceutical composition containing same |
| 09/01/1992 | US5143715 Organic contrast agent analog and method of making same |
| 09/01/1992 | US5143712 Endothelial leukocyte adhesion molecule-1 blocking agent, antiinflammatory agent |
| 09/01/1992 | CA1307003C Phenyl carbamate |
| 09/01/1992 | CA1306995C Cyclic amine and pharmacological composition |
| 09/01/1992 | CA1306994C Cephalosporin derivatives, process for their preparation and antibacterial agents |
| 09/01/1992 | CA1306993C PROCESS FOR THE PRODUCTION OF 17.alpha.-ETHINYL-17.beta.-HYDROXY-18-METHYL-4,15-ESTRADIEN-3-ONE AND NEW INTERMEDIATE PRODUCTS FOR THIS PROCESS |
| 09/01/1992 | CA1306951C Regulating retroviral replication, infection, and pathogenesis |
| 09/01/1992 | CA1306950C Buccal administration of estrogens |
| 09/01/1992 | CA1306945C Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents |
| 09/01/1992 | CA1306944C Lithium salt-containing pharmaceutical compositions |
| 08/29/1992 | WO1992015601A2 Heteroanthracycline antitumor analogs |
| 08/29/1992 | WO1992015563A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
| 08/29/1992 | WO1992015310A1 Use of tricyclic isoindolinones as antiviral drugs, and new, optically active isoindolinones |
| 08/29/1992 | CA2104963A1 Use of tricyclic isoindolinones as anti-viral medicaments as well as new optically-active isoindolinones |
| 08/29/1992 | CA2104879A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof |
| 08/29/1992 | CA2104768A1 Heteroanthracycline antitumor analogs |
| 08/29/1992 | CA2061716A1 Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis |
| 08/28/1992 | WO1992015580A1 NEUROLEPTIC PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES |
| 08/28/1992 | WO1992015561A2 Process for preparing trans-piperidine-2,5-dicarboxylates |
| 08/28/1992 | WO1992015293A1 Treatment of cellulite with retinoids |
| 08/28/1992 | WO1992015289A1 Compositions and methods for topical administration of pharmaceutically active agents |
| 08/28/1992 | CA2061993A1 Fucose-bearing cytostatics |
| 08/28/1992 | CA2061812A1 Substituted cyclic sulphamide derivatives |
| 08/27/1992 | WO1992014474A1 Methods for the treatment of osteoporosis |
| 08/27/1992 | DE4106224A1 6-amino-substd. thymine derivs. e.g. 6-hydrazino:thymine - used for treating growth-factor-dependent tumours e.g. breast, stomach and kidney carcinoma |
| 08/27/1992 | CA2061785A1 Optically active aminoketone derivative and method for preparing |
| 08/27/1992 | CA2061353A1 Prophylactic and curing agent for sequelae of cerebral neurocyte dyscrasia |
| 08/27/1992 | CA2061271A1 Method for the treatment of hepatic failure and disease |
| 08/27/1992 | CA2061159A1 Imidazole and benzimidazole derivatives |
| 08/27/1992 | CA2060746A1 Manufacture of calcium hydrosilicate bound fiberboard |
| 08/26/1992 | WO1992014693A1 Method of preparation of pilocarpines and intermediates thereof |
| 08/26/1992 | WO1992014364A1 Opiate receptor antagonist modulates hyperkinetic movement disorder |
| 08/26/1992 | EP0500443A1 Phenylethanolamino- and phenylethanolaminomethyltetralines, process for their preparation, intermediates of this process and pharmaceutical compositions containing them |
| 08/26/1992 | EP0500426A1 2,6-Dimethyl-4-(4'-hydroxy-3',5'-di-t-butylphenyl)-1,4-dihydropyridine derivatives, process for their preparation and their use as free radical scavengers |
| 08/26/1992 | EP0500409A1 4-Pyrimidinone derivatives, their preparation and their application in therapy |
| 08/26/1992 | EP0500360A1 Quinoline-containing ketoacids as leukotriene antagonists |
| 08/26/1992 | EP0500348A1 Disubstituted ureas and thioureas |
| 08/26/1992 | EP0500337A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes |
| 08/26/1992 | EP0500336A1 Composition containing certain phenol and benzamide for the treatment of type I diabetes |
| 08/26/1992 | EP0500297A1 Substituted pyridinones and pyrimidinones as angiotensin II antagonists |
| 08/26/1992 | EP0500205A1 Benzodioxole derivatives |
| 08/26/1992 | EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate |
| 08/26/1992 | EP0500137A1 1,2,4-Triazolo[1,5-a]pyrimidine derivatives, a process for preparing them as well as medicaments containing them and the use of them |
| 08/26/1992 | EP0500136A1 1,2,4-Triazolo[1,5-a]pyrimidine derivatives, a process for preparing them as well as medicaments containing them and the use of them |
| 08/26/1992 | EP0499995A2 Piperidine derivatives |
| 08/26/1992 | EP0499987A1 Platelet activating factor antagonists |
| 08/26/1992 | EP0499983A1 Nootropic drug |
| 08/26/1992 | EP0499926A1 2-Substituted quinolines, process for their preparation as well as their use in medicaments |
| 08/26/1992 | EP0499920A1 Lacidipine for the treatment of arteriosclerosis |
| 08/26/1992 | EP0499882A1 Pharmaceutical compositions containing N-acetyl-cysteine derivatives useful for the treatment of cataracts |
| 08/26/1992 | EP0499831A2 Combination of active agents comprising a sydnonimin derivate and a hirudin |
| 08/26/1992 | EP0499755A1 Phenylethanolaminotetralines, process for their preparation, intermediates of this process and pharmaceutical compositions containing them |
| 08/26/1992 | EP0499662A1 Compositions with enhanced penetration |
| 08/26/1992 | EP0480925A4 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 08/26/1992 | EP0312541B1 2-(aminoalkylthio)methyl-1,4-dihydropyridine, a method for the preparation thereof and pharmaceutical compositions containing them |
| 08/26/1992 | EP0265508B1 Production and use of reaction product obtained from ascorbic acid with alpha,beta-unsaturated alicyclic ketone or vinyl aliphatic ketone |
| 08/26/1992 | EP0246322B1 Treatment of aids-type disease |
| 08/26/1992 | CN1063897A Process for preparation of sugar |
| 08/26/1992 | CN1063871A Extraction of berberin by salting out with biacid |
| 08/26/1992 | CN1063870A Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes |
| 08/26/1992 | CN1063869A Nitrogenous bicyclic derivatives, their preparation process, intermediates obtained, their use as medicaments and pharomaceutical composition containing them |
| 08/26/1992 | CN1063818A Improved antiperspirant formulations |
| 08/26/1992 | CN1063817A Onychomycosislin and prep. thereof |
| 08/26/1992 | CN1017992B Process for preparing piperidine opioid antagonists |
| 08/26/1992 | CA2104000A1 4-[(2-benzothiazolyl)methylamino] -.alpha.-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol |
| 08/26/1992 | CA2101445A1 Method of preparation of pilocarpines and intermediates thereof |
| 08/26/1992 | CA2061536A1 Use of s-adenosyl-l-menthionine in the treatment of intrahepatic cholestasis determined by total parenteral nutrition |
| 08/26/1992 | CA2037345A1 Endothelial cell-monocyte adhesion molecule |
| 08/25/1992 | US5142094 Anticholesterola gents |
| 08/25/1992 | US5142076 Wound healing agents, microboicides, antiinflammatory agents |
| 08/25/1992 | US5142075 Anti-tumor platinum(II) complexes and process for the preparation thereof |
| 08/25/1992 | US5142056 Human immunodeficiency virus protease inhibitor |
| 08/25/1992 | US5142053 Process for the preparation of 1-(2,3,4-trimethoxybenzyl)piperazine by reductive animation |
| 08/25/1992 | US5142051 Viricides special for mutants of herpes viruses |
| 08/25/1992 | US5142048 Enzyme inhibitor; carbamoyl group-containing acids |
| 08/25/1992 | US5142046 Optically active pyridobenzoxazine derivatives and intermediates thereof |
| 08/25/1992 | US5142041 Cephalosporin intermediates |
| 08/25/1992 | US5141962 N-pentyl-n-phenethyl-3-hydroxyphenethylamine as antagonist for opiate receptor |
| 08/25/1992 | US5141961 Mixing drug, polyethylene glycol, polyvinylpyrrolidone and solvent until dissolved, evaporating solvent |
| 08/25/1992 | US5141959 Antiinflammatory agents |
| 08/25/1992 | US5141958 Inhibition of cell adhesion for reducing cancer cell metastases |
| 08/25/1992 | US5141957 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c |
| 08/25/1992 | US5141955 Anti-inflammatory benzylselenobenzamides made from anilines and benzylamines |
| 08/25/1992 | US5141953 Purpuromycin for the treatment of vaginal infections and pharmaceutical dosage forms for said use |
| 08/25/1992 | US5141952 Heterocyclic dicarboxylic acids |
| 08/25/1992 | US5141951 5-phenyl-1H-pyrazol-4-propionic acid derivatives, compositions and use |
| 08/25/1992 | US5141950 Benzimidazole compounds and their use |
| 08/25/1992 | US5141949 Administering N- 2-(diethylamino)-ethyl!-2-methoxy-4- (1H-4,5-dihydro-2-imidazolyl)-amino!-5-chlorobenzamide or salt |
| 08/25/1992 | US5141947 Fibrinolysis-enhancing agents |
| 08/25/1992 | US5141946 Azole derivatives and anti-ulcerative composition containing same |
| 08/25/1992 | US5141945 5-Hydroxytryptamine antagonists, treatment or prevention of nausea and vomiting |
| 08/25/1992 | US5141943 Water soluble uridine phosphorylase inhibitors, reducing toxicity and anemia of antiviral drugs |
| 08/25/1992 | US5141942 Topical administration for promoting hair growth |
| 08/25/1992 | US5141938 Parasiticidal substituted 1,2,4-triazinediones |
| 08/25/1992 | US5141937 Treatment of hyperlipidemias |
| 08/25/1992 | US5141936 Use of pyrimido-(6,1-a)-isoquinolin-4-one derivatives and medicinal preparations based on these compounds |
| 08/25/1992 | US5141933 Administering an isoindoline compound |